Back to Search Start Over

Trajectory of Unawareness of Memory Decline in Individuals With Autosomal Dominant Alzheimer Disease.

Authors :
UCL - SSS/IONS/NEUR - Clinical Neuroscience
UCL - (SLuc) Service de neurologie
Vannini, Patrizia
Hanseeuw, Bernard
Gatchel, Jennifer R
Sikkes, Sietske A M
Alzate, Diana
Zuluaga, Yesica
Moreno, Sonia
Mendez, Luis
Baena, Ana
Ospina-Lopera, Paula
Tirado, Victoria
Henao, Eliana
Acosta-Baena, Natalia
Giraldo, Margarita
Lopera, Francisco
Quiroz, Yakeel T
UCL - SSS/IONS/NEUR - Clinical Neuroscience
UCL - (SLuc) Service de neurologie
Vannini, Patrizia
Hanseeuw, Bernard
Gatchel, Jennifer R
Sikkes, Sietske A M
Alzate, Diana
Zuluaga, Yesica
Moreno, Sonia
Mendez, Luis
Baena, Ana
Ospina-Lopera, Paula
Tirado, Victoria
Henao, Eliana
Acosta-Baena, Natalia
Giraldo, Margarita
Lopera, Francisco
Quiroz, Yakeel T
Source :
JAMA network open, Vol. 3, no. 12, p. e2027472 [1-14] (2020)
Publication Year :
2020

Abstract

IMPORTANCE: Recent studies have suggested that unawareness, or anosognosia, of memory decline is present in predementia stages of Alzheimer disease (AD) and may serve as an early symptomatic indicator of AD. OBJECTIVE: To investigate the evolution of anosognosia of memory decline in individuals who carry the PSEN1 E280A variant for autosomal dominant AD compared with family members who do not carry the variant. DESIGN, SETTING, AND PARTICIPANTS: This cohort study investigated a total of 2379 members of a Colombian kindred with autosomal dominant AD who were part of the Alzheimer's Prevention Initiative Registry. Assessments were completed at the University of Antioquia, Colombia, with data collected between January 1, 2000, and July 31, 2019. MAIN OUTCOMES AND MEASURES: Awareness of memory function was operationalized using the discrepancy between self-report and study partner report on a memory complaint scale. Linear mixed effects models were used to assess memory self-awareness over age separately in variant carriers and noncarriers. RESULTS: This study included 396 variant carriers (mean [SD] age, 32.7 [11.9] years; 200 [50.5%] female), of whom 59 (14.9%) were cognitively impaired, and 1983 cognitively unimpaired noncarriers (mean [SD] age, 33.5 [12.5] years; 1129 [56.9%] female). The variant carriers demonstrated increased awareness until the mean (SD) age of 35.0 (2.0) years and had anosognosia at approximately 43 years of age, approximately 6 years before their estimated median age of dementia onset (49 years; 95% CI, 49-51 years). Cognitively unimpaired noncarriers reported more complaints than their study partners aged 20 and 60 years (10.1 points, P < .001). On the awareness index, a decrease with age (mean [SE] estimate, -0.04 [0.02] discrepant-points per years; t = -2.2; P = .03) in the noncarriers and in the variant carriers (mean [SE] estimate, -0.21 [0.04] discrepant-points per years; t = -5.1; P < .001) was observed. CONCLUSIONS AND RELEVANCE: In thi

Details

Database :
OAIster
Journal :
JAMA network open, Vol. 3, no. 12, p. e2027472 [1-14] (2020)
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1288283344
Document Type :
Electronic Resource